Showing 1771-1780 of 3451 results for "".
Rhatigan to Merz, MOC Dissatisfaction, Syneron-Candela Sale
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-rhatigan-to-merz-moc-dissatisfaction-syneron-candela-sale/18485/Industry veteran Bob Rhatigan is the new President and Chief Executive Officer of Merz North America. Patrick Urban is new Chief Commercial Officer. In a transaction valued at approximately $397 million, an affiliate of funds advised by Apax Partners will acquire all of the outstanding shares of SyDermWireTV: PCA to Space Station; ASDS Pandemic Data; LaRoche-Posay, GW Partnership
https://practicaldermatology.com/topics/practice-management/dermwiretv-pca-to-space-station-asds-pandemic-data-laroche-posay-gw-partnership/20059/The "Great Resignation" forcing some dermatology practices to operate with reduced staffing is just one of the lingering impacts of the COVID-19 pandemic on practices, according to results of a survey by the American Society for Dermatologic Surgery. PCA skin is sending the first-ever private sectorDr. Garden Discusses Experience with the VariLite Laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dr-garden-discusses-experience-with-gemini-laser/19467/"The VariLite system is a wonderful choice for those people who want to enter into the laser arena. Because many, many patients have vessels which naturally occur as they grow older or especially those who develop rosacea later in life, this is something that many practices have the need for treatDermWireTV: Arcutis Survey on PsO Impact; Tinted Sunscreen Update; Cosmetic Interventions and Illness; Dr. Seemal Desai Elected
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-arcutis-survey-on-pso-impact-tinted-sunscreen-update-cosmetic-interventions-and-illness-dr-seema-desai-elected/20089/Arcutis Biotherapeutics' survey finds Individuals with psoriasis who use topical treatments want more effective and simpler interventions. Intertriginous disease poses particular challenges. Increased availability of tinted sunscreens could increase the use of SPF among individuals with darker skinDermWireTV: GlobalSkin, ILDS Collab; New approach with Tafinlar; Equity in Telehealth; Dupixent pen
https://practicaldermatology.com/topics/practice-management/dermwiretv-globalskin-ilds-collab-new-approach-with-tafinlar-equity-in-telehealth-dupixent-pen/19952/A data analysis presented at the 2021 American Society of Clinical Oncology Annual Meeting shows that a new approach to managing fevers associated with dabrafenib increases treatment tolerability and avoids discontinuation of therapy. Global Skin (International Alliance of Dermatology Patient OrganiPrurigo Nodularis: An Update for Clinicians, Part 2
https://practicaldermatology.com/topics/atopic-dermatitis/prurigo-nodularis-an-update-for-clinicians-part-2/20490/Here's a look at the management of this condition, which is commonly associated with atopic dermatitis.Physicians Have a Duty to Disobey
https://practicaldermatology.com/topics/practice-management/physicians-have-a-duty-to-disobey/24208/When I was in high school in the 1970s, we were required to read Henry David Thoreau’s essay, Civil Disobedience. We were taught that when confronted with something clearly wrong or unethical, it is our duty to stand up against it—even if it means not abiding by unjust laws or rules. We were to liveCan You Afford to Opt Out of Medicare?
https://practicaldermatology.com/topics/practice-management/can-you-afford-to-opt-out-of-medicare/23884/What to consider when making the the decision and the steps to take.Ask Dr. Friedman
https://practicaldermatology.com/topics/psoriasis/ask-dr-friedman/23360/Answers to Your Questions About Skincare, Disease Management, and MoreThe Microbiome in Atopic Dermatitis: Where Are We Now?
https://practicaldermatology.com/topics/atopic-dermatitis/the-microbiome-in-atopic-dermatitis-where-are-we-now/23746/It seems increasingly likely that microbes will play a central role in understanding AD and its treatments.